Good price Orlistat CAS NO.96829-58-2

Orlistat Tetrahydrolipstatin CAS 96829-58-2 for Cutting Fat

Orlistat / tetrahydrolipstatin
CAS 96829-58-2
M. F: C29H53NO5
M. W: 495.73
Purity: 99%
Appearance: Off white powder
Storage: Shading, confined preservation
Drug Class: Anabolic Androgenic Steroid
Package: Discreet Packing ways for your choice.

Description:

Orlistat (also known as tetrahydrolipstatin) is a drug designed to treat obesity. It is marketed as a prescription drug under the trade name Xenical by Roche in most countries, and is sold over-the-counter as Alli by GlaxoSmithKline in the United Kingdom and the United States. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.

Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity drug.

Application:

Our top quality steroids powder and these excellent service would enable

Orlistat blocks some of the fat that you eat, keeping it from being absorbed by your body. Orlistat is used together with a reduced-calorie diet and weight maintenance to treat obesity in people with certain risk factors (such as diabetes, high blood pressure, and high cholesterol or triglycerides).
Orlistat also modestly reduces blood pressure, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.

Orlistat is notorious for its gastrointestinal side effects (sometimes referred to as treatment effects), which can include steatorrhea (oily, loose stools). These decrease with time, however, and are the most frequently reported adverse effects of the drug. In the United States and the European Union, orlistat is available for sale without a prescription. Over-the-counter approval was controversial in the United States, with consumer advocacy group Public Citizen repeatedly opposing it on safety and efficacy grounds. Generic formulations of orlistat are available in some countries.